ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
C

Lecture Summary - ASCO 2022 on a Post Hoc Analysis of Sustained MRD Negativity From the GRIFFIN Trial: Dara + Len, Bortezomib, and Dex in Transplant-Eligible NDMM

By ASCO 2022 Conference Coverage FEATURING Cesar Rodriguez
By ASCO 2022 Conference Coverage FEATURING Cesar Rodriguez
16 views
July 11, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
Myeloma
01:26

Lecture Summary - ASCO 2022 on a Post Hoc Analysis of Sustained MRD …

ASCO 2022 Conference Coverage

C. Rodriguez

16 views
04:46

ASCO 2022 on a Post Hoc Analysis of Sustained MRD Negativity From th…

ASCO 2022 Conference Coverage

C. Rodriguez

136 views
05:05

ASCO 2022 on Elranatamab, a BCMA-Targeted T-Cell Redirecting Immunot…

ASCO 2022 Conference Coverage

A. Jakubowiak

103 views
01:00

Lecture Summary - ASCO 2022 on Elranatamab, a BCMA-Targeted T-Cell R…

ASCO 2022 Conference Coverage

A. Jakubowiak

17 views
07:36

ASCO 2022 on the Changing Landscape in Post-Transplant Treatment of …

ASCO 2022 Conference Coverage

A. Jakubowiak

75 views
01:07

Lecture Summary - ASCO 2022 Subgroup Analysis of the Phase 3 CASTOR …

ASCO 2022 Conference Coverage

A. Spencer

15 views
04:19

ASCO 2022 Subgroup Analysis of the Phase 3 CASTOR and POLLUX Studies…

ASCO 2022 Conference Coverage

A. Spencer

22 views
05:09

ASCO 2022 on Myeloma Developing Regimens Using Genomics (MyDRUG) Tri…

ASCO 2022 Conference Coverage

S. Kumar

55 views
50

Lecture Summary - ASCO 2022 on Myeloma Developing Regimens Using Gen…

ASCO 2022 Conference Coverage

S. Kumar

10 views
04:01

Lecture Summary - ASCO 2022 Safety and Clinical Activity of Belantam…

ASCO 2022 Conference Coverage

A. Suvannasankha

14 views
05:20

Health-Related Quality of Life in R/R MM Treated With Teclistamab, a…

Thomas Martin

773 views
03:09

ASCO 2022 Comparative Effectiveness of Teclistamab vs. Real-World Tr…

ASCO 2022 Conference Coverage

A. Krishnan

18 views
37

Lecture Summary - ASCO 2022 Comparative Effectiveness of Teclistamab…

ASCO 2022 Conference Coverage

A. Krishnan

14 views
01:22

Lecture Summary - ASCO 2022 Health-Related Quality of Life in R/R MM…

ASCO 2022 Conference Coverage

T. Martin

22 views
50

Lecture Summary - ASCO 2022 Birtamimab in Pts With Mayo Stage IV AL …

ASCO 2022 Conference Coverage

M. Gertz

259 views
05:05

ASCO 2022 Birtamimab in Pts With Mayo Stage IV AL Amyloidosis: Ratio…

ASCO 2022 Conference Coverage

M. Gertz

614 views
32

Lecture Summary - ASCO 2022 on B-PRISM: A Phase II Trial of Combinat…

ASCO 2022 Conference Coverage

O. Nadeem

24 views
05:59

ASCO 2022 on B-PRISM: A Phase II Trial of Combination of Daratumumab…

ASCO 2022 Conference Coverage

O. Nadeem

77 views
01:29

Lecture Summary - ASCO 2022 on the Addition of Carfilzomib as a Thir…

ASCO 2022 Conference Coverage

C. Cerchione

92 views
11:29

ASCO 2022 on the Addition of Carfilzomib as a Third Agent in Lenalid…

ASCO 2022 Conference Coverage

C. Cerchione

377 views